GlassScriptPhysician profile
Ramanathan Muthaiah
NPI 1356367734
$1,508.33
in general payments reported to CMS, 2019-2025
20 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $95.65 · 2021: $192 · 2022: $171 · 2023: $172 · 2024: $136 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $297.88 | 2019-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $260.59 | 2019-2025 | Breztri, Airsupra |
| Amgen INC. | $165.23 | 2022-2025 | Otezla, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.09 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $110.01 | 2019-2023 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $76.61 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $55.39 | 2022 | |
| Boston Scientific Corporation | $52.95 | 2025 | General - Pain Management |
| Astellas Pharma US INC | $46.86 | 2024 | Veozah |
| Abbvie INC. | $46.15 | 2023-2025 | |
| Pfizer INC. | $35.01 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.67 | 2019-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $30.99 | 2019-2021 | |
| Lilly USA, LLC | $28.12 | 2022-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $28.02 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23.95 | 2019 | |
| Intra-Sana Laboratories | $19.56 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Medline Industries LP | $16.22 | 2022 | |
| Exact Sciences Corporation | $13.46 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramanathan Muthaiah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.